ClinicalTrials.Veeva

Menu

Maternal and Fetal Outcomes in Pregnant Women With COVID -19,a Cross Sectional Study

Cairo University (CU) logo

Cairo University (CU)

Status

Completed

Conditions

COVID-19 Pandemic

Study type

Observational

Funder types

Other

Identifiers

NCT05608616
COVID-19 and pregnancy

Details and patient eligibility

About

The spread of a new coronavirus (SARS-CoV-2) from Wuhan, China, has been fast, and the World Health Organization (WHO) declared a pandemic on March 11th, 2020 .It has now spread worldwide and is one of the most severe public health threats.The clinical characteristics of COVID-19 and the likelihood of transmission vertically or during delivery in pregnant women are still unknown.

Full description

In this cross sectional study,the following questions require immediate attention: whether COVID-19 symptoms in pregnant women differ from symptoms in non-pregnant women; whether disease complications and mortality rates are higher in pregnant women than in non-pregnant women; and whether there is a risk of premature delivery, foetal mortality, or even vertical transmission of the disease. These questions must be answered in order to plan optimal obstetrical management for pregnant women with COVID-19

Enrollment

70 patients

Sex

Female

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Pregnant women of any gestational age with confirmed COVID 19 diagnosis attended and admitted at inpatient ward for management and follow up from April 2020 to December 2021at Kasr El Ainy hospital,Cairo university

Exclusion criteria

  • there is no exclusion criteria

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems